voriconazole has been researched along with Mycoses in 622 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (0.96) | 18.2507 |
2000's | 237 (38.10) | 29.6817 |
2010's | 321 (51.61) | 24.3611 |
2020's | 58 (9.32) | 2.80 |
Authors | Studies |
---|---|
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E | 1 |
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
Dho, G; Esposto, MC; Gianni, C; Grancini, A; Ossi, C; Prigitano, A; Tortorano, AM; Viviani, MA | 1 |
Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR | 1 |
Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S | 1 |
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 1 |
Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
Wang, SQ; Wang, YF; Xu, Z | 1 |
Aragona, P; Biondo, C; Inferrera, L; Postorino, EI; Roszkowska, AM; Severo, AA | 1 |
D'agostino, M; Debourgogne, A; Frippiat, JP; Lavergne, RA; Le Pape, P; Machouart, M; Tesse, N | 1 |
Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
Amiri, S; Borjian Boroujeni, Z; Getso, MI; Hashemi, SJ; Raiesi, O; Raissi, V; Yarahmadi, M | 1 |
Deng, S; Hu, Q; Li, Y; Sun, S; Tang, M | 1 |
Al-Hatmi, AMS; Blechert, O; Hu, F; Jiang, Q; Wang, C; Wang, P; Zhan, P; Zhang, L | 1 |
Cornely, O; Janssen, S; Mehler, K; Oberthuer, A; Seifert, H; Zweigner, J | 1 |
Arunga, S; Burton, MJ; Chaudhary, P; Hoffman, JJ; Hu, VH; Leck, A; Macleod, D; Mishra, SK; Roshan, A; Sanyam, SD; Singh, SK; Yadav, R | 1 |
Allameen, NA; Cho, J | 1 |
Acharya, NR; Das, M; Devi, L; Krishnan, T; Lalitha, P; Lietman, TM; Liu, Z; Porco, TC; Prajna, NV; Radnakrishnan, N; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, ME | 1 |
Aykaç, K; Başaran, E; Büyükköroğlu, G; Demirel, M; Tunali, Y; Yenilmez, E | 1 |
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 1 |
Chelnokova, IA; Karachrysafi, S; Karampatakis, V; Kavvadas, D; Komnenou, A; Papadopoulou, K; Papaliagkas, V; Papamitsou, T; Samara, P; Shkliarava, NM; Sioga, A; Starodubtseva, MN | 1 |
Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX | 1 |
Cai, DH; Fang, XL; Wang, J | 1 |
de Lima-Neto, RG; de Melo, HRL; de Sousa, BR; Neves, RP; Silva, GM; Torres, KB | 1 |
Aliakbarian, M; Khaleghi, E; Khodashahi, M; Khodashahi, R; Moghaddam, MD; Naderi, HR; Pasand, MM; Rezayat, KA | 1 |
Kwon, T; Maish, D; Martinez, RM; Shelly, MA; Tabliago, NRA; Yablonski, B | 1 |
Gómez-López, A; Martín-Gómez, MT; Salavert Lletí, M | 1 |
Ding, C; He, X; Li, B; Peng, J | 1 |
Bryson, AL; Doern, CD; Pierce, J; Sayeed, S | 1 |
Boyd, S; Mahmoudjafari, Z; Martin, GA; Perry, C; Scott, SA; Thomas, B; Thompson, J | 1 |
An, L; Jia, G; Li, L; Tan, J; Wang, Y; Yang, L | 1 |
Chen, J; Shen, X; Tang, G; Yan, K; Yan, L; Yao, H; Yuan, X | 1 |
Farkas, M; Hauser, P; Kassa, C; Kelemen, Á; Pásztor-Bazsó, V; Puskás, N; Varga, Á | 1 |
Hustrini, NM; Panggabean, SD | 1 |
Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP | 1 |
Cao, CW; Fu, YJ; Guo, J; Huang, CY; Li, BK; Li, TM; Pan, KS; Wei, FL; Zheng, YQ | 1 |
Akune, Y; Inoshima, Y; Kobayashi, M; Ohno, Y | 1 |
Abbas-Aghababazadeh, F; Caceres, G; Fridley, BL; Greene, JN; Hicks, JK; Kelly, K; Komrokji, RS; Kubal, TE; Lancet, JE; McLeod, HL; Pasikhova, Y; Qin, D; Quilitz, RE; Salchert, YS; Shahbazian, K; So, W; Velez, AP | 1 |
Li, R; Sun, L; Wan, Z; Yu, J | 1 |
Feng, RZ; Jiang, HL; Liu, W | 1 |
Akune, Y; Inoshima, Y; Kano, R; Ohno, Y | 1 |
Andrade, A; Bodden-Mendoza, BA; Espinosa-Mora, JE; González, GM; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H | 1 |
Główka, FK; Kosicka, K; Krawiec, J; Resztak, M; Zalewska, P | 1 |
Almeida-Paes, R; Brito-Santos, F; Coelho, RA; da Silva Chaves, AL; de Oliveira, JCA; Figueiredo-Carvalho, MHG; Monteiro, RV | 1 |
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Hortas, A; Blanco-Dorado, S; Campos-Toimil, M; Carracedo, Á; Durán Piñeiro, G; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I | 1 |
Biswas, J; Kumar, A; Madhuravasal Krishnan, J; Roy, R; Singh, P | 1 |
Carlesse, F; Cheng, MP; Cornely, OA; Falces-Romero, I; Hassler, A; Herbrecht, R; Jover Sáenz, A; Klimko, N; Koehler, P; Lass-Flörl, C; Lehrnbecher, T; Mareş, M; Mellinghoff, SC; Pana, Z; Salmanton-García, J; Seidel, D; Soler-Palacín, P; Wisplinghoff, H | 1 |
Li, H; Luo, J; Shi, L; Wang, L; Zeng, G; Zhang, Z; Zhu, M | 1 |
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M | 1 |
Bhaskaran, V; Chandran, S; Dinesh, K; Khan, S; Kumar, A | 1 |
Enoki, Y; Ikegame, K; Izumikawa, K; Matsumoto, K; Mayumi, T; Miyazaki, T; Miyazaki, Y; Okinaka, K; Takada, T; Takesue, Y; Uchino, M; Ueda, T; Yamashita, C | 1 |
Krishnan, T; Lietman, TM; Narayana, S; Pickel, J; Porco, TC; Ramakrishnan, S; Redd, T; Rose-Nussbaumer, J; Samantaray, PP | 1 |
Aggarwal, A; Banerjee, S; Biswas, A; George, N; Gupta, N; Jorwal, P; Kodan, P; Kumar, P; Kumar, R; Malla, S; Ramteke, P; Ray, Y; Singh, G; Soneja, M | 1 |
Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF | 1 |
Chen, T; Gao, L; Li, H; Li, M; Li, Q; Qiang, W; Shi, Q; Wang, J; Wang, T; Wang, Y; Yan, J; Zhang, Y; Zheng, J; Zhou, L | 1 |
Amanati, A; Badiee, P; Bozorgi, H; Faghihi, MA; Lotfi, M; Manen, RV; Mazinani, NH; Yavarian, M; Zekavat, O | 1 |
Fujioka, T; Itoh, H; Iwao, M; Suzuki, Y; Tanaka, R | 1 |
Alffenaar, JW; Cotta, MO; Daveson, K; Imani, S; Lau, C; Marriott, D; Penm, J; Roberts, JA; Sandaradura, I; Tabah, A; Trethewy, N; van Hal, S; Williams, P | 1 |
Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF | 1 |
Bautista-de Lucio, VM; Calvillo-Medina, RP; Campos Guillén, J; Escudero-Leyva, E; Müller-Morales, CA; Ponce-Angulo, DG; Raymundo, T | 1 |
Guarro, J; Pérez-Cantero, A | 1 |
Machida, M; Miyazaki, Y; Nakamura, I; Nakamura, S; Sato, A; Watanabe, H | 1 |
Cornely, OA; Falces-Romero, I; Hatvani, L; Heinemann, M; Klimko, N; López-Soria, L; Malaj, X; Meletiadis, J; Sal, E; Salmanton-García, J; Seidel, D; Shruti, M; Sprute, R; Steinmann, J; Stemler, J | 1 |
Lam, JKW; Liao, Q | 1 |
Fujibayashi, A; Harada, S; Hoshino, Y; Niwa, T; Suzuki, A | 1 |
Cao, C; Huang, W; Jiang, J; Li, T; Wei, F; Zhou, C | 1 |
Cai, J; Chen, H; Shi, T; Wu, L | 1 |
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
Beeckmans, H; Bos, S; De Mol, W; Lagrou, K; Spriet, I; Verleden, GM; Vos, R | 1 |
Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
Birch, M; Law, D; Wiederhold, NP | 1 |
Cohen, N; Eaton, A; Kobos, R; Seo, SK; Seyboth, B; Yan, SQ | 1 |
Bachellier, P; Bru, V; Gourieux, B; Herbrecht, R; Launoy, A; Levêque, D; Lutun, P; Nivoix, Y; Poulat, C; Rohr, S; Woehl, ML | 1 |
Ahlawat, S; Hazarika, N; Sen, IB; Shirshi, N; Tiwari, P | 1 |
Anzawa, K; Mochizuki, T; Watanabe, S | 1 |
Karagas, MR; Kuklinski, LF; Kwong, BY; Li, S; Weng, WK | 1 |
Chatzistilianou, M; Doganis, D; Grafakos, S; Kattamis, A; Katzilakis, N; Koliouskas, D; Kourti, M; Paisiou, A; Pana, ZD; Papageorgiou, M; Petrikkos, L; Polychronopoulou, S; Roilides, E; Stiakaki, E; Vasilatou-Kosmidis, H; Vikelouda, K; Vlahou, A | 1 |
Acharya, NR; Das, M; Krishnan, T; Lietman, TM; McLeod, SD; Oldenburg, CE; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Srinivasan, M; Zegans, ME | 1 |
Aydin, F; Cebeci Güler, N; Tosun, I | 1 |
Allender, MC; Archer, G; Baitchman, E; Chu, CT; Cox, S; Driskell, EA; Hsiao, SH; Kane, L; Lindemann, DM; Rzadkowska, M; Singh, K; Sykes, JM | 1 |
Annino, L; Arcioni, F; Barberi, W; Bertaina, A; Carotti, A; Cartoni, C; Caselli, D; Cassetta, MI; Cerchiara, E; Cupelli, L; Fallani, S; Fanci, R; Ferrari, A; Girardi, K; Girmenia, C; Marchesi, F; Mariotti, B; Novelli, A; Proia, A; Ribersani, M; Venditti, A | 1 |
Abela, IA; Benden, C; Imkamp, F; Mueller, NJ; Muller, F; Murer, C; Schmitt, JW; Schuurmans, MM | 1 |
Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT | 1 |
Bes, D; Lede, R; Rosanova, MT; Sberna, N; Serrano Aguilar, P | 1 |
Chen, Y; Guo, XB; Jiang, Y; Mao, Q; Yi, XL | 1 |
Léguillette, R; Scott, M; Whitehead, AE; Whitty, J | 1 |
Akiyama, H; Hirato, J; Hoshino, J; Makimura, K; Todokoro, D; Yo, A | 1 |
Asano, S; Kato, K; Sakurada, H; Tachi, T; Teramachi, H; Yamamura, M; Yasuhara, K; Yoshida, M | 1 |
Allan, GS; Anderson, KM; Davies, S; Dennis, PM; Malik, R; Rose, JB | 1 |
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP | 1 |
Fukuoka, N; Imataki, O; Uemura, M; Yamaguchi, K | 1 |
Dai, C; Kan, J; Li, M; Shan, W; Yin, M | 1 |
Imai, S; Iseki, K; Kagami, K; Koshizuka, Y; Shimamura, T; Sugawara, R; Tazawa, Y; Tomiyama, N; Yamada, T; Yamagami, A | 1 |
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
Ge, Y; Hu, Y; Huang, M; Xu, Z | 1 |
Arianayagam, M; Jeffery, N; Kam, J; Ling, KY; Winter, M | 1 |
Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM | 1 |
Barbeito Castiñeiras, G; Blanco-Dorado, S; Campos-Toimil, M; Cea-Arestin, C; Fernández-Ferreiro, A; González Carballo, A; Lamas, MJ; Latorre-Pellicer, A; Maroñas Amigo, O; Pérez Del Molino Bernal, ML | 1 |
Bao, SS; Chen, MC; Chen, RJ; Cui, X; Dong, YY; Hu, GX; Lou, D; Pan, WH; Sun, W; Wang, Z | 1 |
Carlesse, FAMC; de Araujo, OR; Marques, LMA; Petrilli, AS; Senerchia, AA; Silva, DCBD | 1 |
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH | 1 |
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M | 1 |
Chen, YH; Li, DM; Li, RY; Liu, W; Song, YG; Sun, LN; Sun, TT; Zhang, GJ; Zhou, YB | 1 |
Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
Kawakami, J; Mino, Y; Naito, T; Yamada, T | 1 |
McLaren, A; McLemore, R; Pauken, C; Schmidt, K | 1 |
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC | 1 |
Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K | 1 |
Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A | 1 |
Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N | 1 |
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M | 1 |
Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I | 1 |
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ | 1 |
Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
Flynn, PM; Hayden, RT; Knapp, KM; Maron, GM; Rodriguez, A; Rubnitz, JE; Shenep, JL | 1 |
Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR | 1 |
Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ | 1 |
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C | 1 |
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA | 1 |
Leroux, S; Ullmann, AJ | 1 |
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H | 1 |
Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S | 1 |
Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE | 1 |
Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ | 2 |
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
Kim, DY; Lee, YJ; Park, HJ | 1 |
Ascioglu, S; Chan, KA | 1 |
Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ | 1 |
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
Davidson-Moncada, J; Drinkwater, DC; Heckendorn, E; Myers, J; Whitman, TJ | 1 |
Araoka, H; Asano-Mori, Y; Hayashi, M; Ishiwata, K; Ito, T; Izutsu, K; Kaji, D; Makino, S; Masuoka, K; Matsuno, N; Nishida, A; Ota, H; Takagi, S; Taniguchi, S; Tsuji, M; Uchida, N; Uchida, Y; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A | 1 |
Paratz, E; Slavin, MA; Teh, BW; Thursky, KA; Todaro, M; Trubiano, JA; Wolf, M | 1 |
Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS | 1 |
Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B | 1 |
Bang, J; Felton, E; Fermo, O; Johnson, K; Llinas, R; Nelson, G; Rhee, S; Sullivan, D; Thakur, K; Wilson, L | 1 |
Gundlapalli, S; Gupta, KL; Kaur, H; Kohli, HS; Kumar, V; Mohindra, S; Ramachandran, R; Rathi, M; Sakhuja, V | 1 |
Barbui, A; Boccadoro, M; Brunello, L; Bruno, B; Ferrando, F; Festuccia, M; Gay, F; Giaccone, L; Maffini, E; Serra, R; Talamo, E | 1 |
Enderby, CY; Heckman, MG; Keller, CA; Thomas, CS | 1 |
Fung, HC; Peksa, GD; Schultz, K | 1 |
Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA | 1 |
Clancy, CJ; Johnson, LS; Shields, RK | 1 |
Cen, X; Dong, Y; Li, Y; Liang, Z; Liu, W; Ou, J; Qiu, Z; Ren, H; Sun, Y; Wang, L; Wang, M; Wang, Q; Xu, W | 1 |
Choong, K; Hirst, LW; Playford, EG | 1 |
Tang, S | 1 |
Chen, T; Dong, F; Guo, X; Hu, B; Hu, H; Li, S; Li, Z; Liu, G; Wang, Q; Yao, K; Zhang, Z | 1 |
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F | 1 |
Dolton, MJ; McLachlan, AJ | 1 |
Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
Fujita, Y; Ikeda, Y; Kasahara, H; Sekine, A; Tsukagoshi, S; Tsutsumi, Y | 1 |
Amilien, V; Chauvin, B; Eloy, P; Francois, H; Furlan, V; Lecefel, C; Massias, L; Taburet, AM; Wyplosz, B | 1 |
Flynn, HW; Miller, D; Silva, RA; Sridhar, J; Wykoff, CC | 1 |
Guo, D; Hawryluk, EB; Huang, JT; London, WB; Sheu, J | 1 |
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
Ahmed, Y; Albrecht, H; Siddiqui, W; Weissman, S | 1 |
Dalgıç, B; Demirtaş, Z; Kalkancı, A; Kara, SS; Polat, M; Sarı, S; Tapısız, A; Tezer, H | 1 |
Crowe, A; Slavin, MA; Thursky, KA; Trubiano, JA; Worth, LJ | 1 |
Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Murata, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
Botterel, F; Bougnoux, ME; Compain, F; Dannaoui, E; Paugam, A; Sitterlé, E | 1 |
Doi, A; Hiramoto, N; Ichikawa, C; Imai, Y; Ishikawa, T; Ochi, Y; Takegawa, H; Yonetani, N | 1 |
Barajas, MR; Bartoo, GT; Dierkhising, RA; El-Azhary, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; Merten, JA; Patnaik, MM; Plevak, MF; Wilson, JW; Wojenski, DJ; Wolf, RC | 1 |
Lekhanont, K; Nimvorapun, N; Nonpassopon, M; Santanirand, P | 1 |
Gong, B; Li, W; Lin, D; Liu, B; Liu, K; Liu, Y; Mi, Y; Wang, J; Wang, Y; Wei, H; Wei, S; Zhang, G; Zhao, X | 1 |
Aliyu, SH; Brown, NM; Enoch, DA; Micallef, C; Rosembert, D; Santos, R | 1 |
Acharya, NR; Keenan, JD; Krishnan, KT; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M | 1 |
Chaptini, C; Gordon, DL; Kennedy, B; Larcombe, R | 1 |
Boan, P; Heath, CH; Lavender, M; Lim, KP; Musk, M; Stathakis, A; Wrobel, J | 1 |
Marr, K; Ostrander, D; Shoham, S | 1 |
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP | 1 |
Amorim, A; Araujo, R; Oliveira, M; Sampaio-Maia, B | 1 |
Akan, H; Atilla, E | 1 |
Chayakulkeeree, M; Maneerattanaporn, M; Poovipirom, N; Siengwattana, P | 1 |
Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V | 1 |
Cerar, T; Krivec, U; Matos, T; Pirš, M; Praprotnik, M | 1 |
El-Bardissy, A; El-Mekaty, E; Elewa, H; Ensom, MH; Wilby, KJ | 1 |
Chemla, C; Huguenin, A; Noel, V; Rogez, A; Toubas, D; Villena, I | 1 |
Andreoni, S; Bargiacchi, O; Buccheri, C; Garavelli, PL; Rossati, A; Sainaghi, PP | 1 |
Dobson, EC; Eden, P; Hooper, C; Scheelings, TF | 1 |
de Sá, FA; Gelfuso, GM; Gratieri, T; Lima, EM; Taveira, SF | 1 |
Blooi, M; Haesebrouck, F; Martel, A; Pasmans, F; Rouffaer, L; Vercammen, F | 1 |
Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K | 1 |
Bell, GC; Greene, JN; Mason, NT; McLeod, HL; Quilitz, RE | 1 |
Cheng, SC; Kuo, CN; Lai, LJ; Lin, YY | 1 |
Agarwal, R; Delproposto, Z; Rheinboldt, M | 1 |
Peghin, M; Ruiz-Camps, I | 1 |
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
Kauffman, CA; Kerr, LE; Malani, AN | 1 |
Chen, L; Dong, H; Dong, Y; Lei, J; Wang, T; Wang, X; Wang, Y; Xie, J; Xing, J; Yang, Q; Zheng, X | 1 |
Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R | 1 |
Allizond, V; Banche, G; Barbui, A; Cuffini, AM; Fucale, G; Li Vigni, N; Mandras, N; Newell, VA; Roana, J; Scalas, D; Tullio, V | 1 |
Conrad, D; Turner, LD | 1 |
Barajas, MR; Bartoo, GT; Dierkhising, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; McCullough, KB; Merten, JA; Patnaik, MM; Wermers, RA; Wilson, JW; Wolf, RC | 1 |
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
Cho, EY; Choi, EH; Kang, HJ; Kang, HM; Lee, H; Lee, HJ; Lee, JW; Park, KD; Shin, HY; Yu, KS | 1 |
Hishiki, H; Ishiwada, N; Kamei, K; Nagasawa, K; Shimojo, N; Takeshita, K; Takeuchi, N; Watanabe, A; Yaguchi, T | 1 |
Sharma, A; Singh, D | 1 |
Barletta, V; Bongiorni, MG; Cardinali, G; Colabella, C; Consorte, A; Corte, L; Di Paolo, A; Leonildi, A; Menichetti, F; Pasticci, MB; Roscini, L; Tascini, C; Zucchelli, G | 1 |
Matsumoto, Y; Ogawa, A; Shimmura, S; Tsubota, K; Yaguchi, T | 1 |
Davies, S; Dell, S; Filipovich, A; Fukuda, T; Kissell, D; Lane, A; Mehta, P; Nortman, S; Teusink, A; Vinks, A; Zhang, K | 1 |
Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K | 1 |
Slavin, MA; Thursky, KA | 1 |
Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B | 1 |
Compagnon, P; Duflot, T; El Kholy, M; Lamoureux, F; Metsu, D; Morisse-Pradier, H; Pereira, T; Stojanova, J; Thiberville, L; Thuillez, C; Woillard, JB | 1 |
Capilla, J; Guarro, J; Mayayo, E; Paredes, K | 1 |
Kachuei, R; Khodavaisy, S; Rezaie, S; Sharifynia, S | 1 |
Meenakshi, R; Ramakrishnan, R; Rameshkumar, G; Rathi, H; Venugopal, A | 1 |
Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX | 1 |
Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J | 1 |
Chen, K; Falcione, BA; Hui, J; Jin, H; Olsen, KM; Tang, H; Wang, T; Zhai, S | 1 |
Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Raghavan, A; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, M | 1 |
Siddiqui, AS; Zimmerman, JL | 1 |
Al-Dabbagh, M; Groll, AH; Husain, S; Luong, ML; Mitsani, D; Nannya, Y; Racil, Z | 1 |
Altınbas, R; Ilkit, M; Kiraz, N; Ozdemir, HG; Sav, H; Seyedmousavi, S | 1 |
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
Chen, K; Li, X; Tang, H; Wang, T; Yu, C; Zhai, S | 1 |
Kato, S; Konuma, T; Kurokawa, Y; Takahashi, S; Tojo, A; Yasu, T | 1 |
Rathi, HS; Ravindran, M; Rengappa, R; Venugopal, A | 1 |
McLaren, O; Potter, C | 1 |
Melnychuk, EM; Sole, DP | 1 |
Gwee, A; Phillips, D; Wen, SC | 1 |
Cai, S; Guo, X; Ren, J; Yuan, W | 1 |
Capilla, J; González, GM; Guarro, J; Lackner, M; Lass-Flörl, C; Martin-Vicente, A | 1 |
Akyürek, N; Aydın Kaynar, L; Aygencel, G; Güzel Tunçcan, Ö; Kalkancı, A; Özkurt, ZN; Ülküden, B | 1 |
González, GM; Renpenning-Carrasco, EW; Treviño-Rangel, RJ; Villanueva-Lozano, H | 1 |
Buer, J; Dittmer, S; Haase, G; Kirchhoff, L; Olsowski, M; Rath, PM; Sedlacek, L; Steinmann, E; Steinmann, J; Zilmans, K | 1 |
Altman, RB; Barbarino, JM; Klein, TE; Owusu Obeng, A | 1 |
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M | 1 |
Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R | 1 |
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV | 1 |
Buchta, V; Vale-Silva, LA; Vejsova, M | 1 |
Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y | 1 |
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K | 1 |
Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST | 1 |
Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC | 1 |
Maesaki, S; Tarumoto, N | 1 |
Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K | 1 |
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T | 1 |
Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S | 1 |
Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A | 1 |
Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B | 1 |
Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T | 1 |
Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN | 1 |
Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K | 1 |
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH | 1 |
Maschmeyer, G | 1 |
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J | 1 |
Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T | 1 |
Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C | 1 |
Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N | 1 |
Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T | 1 |
Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K | 1 |
Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF | 1 |
Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M | 1 |
Lass-Flörl, C; Perkhofer, S | 1 |
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L | 1 |
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S | 1 |
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S | 1 |
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
Marriott, D; Miyakis, S; Ray, J; van Hal, SJ | 1 |
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G | 1 |
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF | 1 |
Lewis, JS; Thompson, GR | 1 |
Drusano, GL | 1 |
Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T | 1 |
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF | 1 |
Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T | 1 |
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M | 1 |
Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL | 1 |
Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA | 1 |
Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC | 1 |
Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T | 1 |
Li, H; Lu, Q; Wan, Z; Zhang, J | 1 |
Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R | 2 |
Buzina, W; Horré, R; Lackner, M; Tintelnot, K | 1 |
Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K | 1 |
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J | 1 |
Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH | 1 |
Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L | 1 |
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
Corey, M | 1 |
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P | 1 |
Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K | 1 |
Elston, DM | 1 |
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
Arron, ST; Ibrahim, SF; Singer, JP | 1 |
Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
Kondori, N; Mattsby-Baltzer, I; Svensson, E | 1 |
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 1 |
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F | 1 |
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P | 1 |
Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M | 1 |
Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND | 1 |
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T | 1 |
Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K | 1 |
Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P | 1 |
Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C | 1 |
Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V | 1 |
Guarro, J; Pastor, J; Ruíz-Cendoya, M | 1 |
Accoceberry, I; Gabriel, F; Noel, T | 1 |
Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S | 1 |
Cecil, JA; Wenzel, RP | 1 |
Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM | 1 |
Arora, R; Goyal, J; Gupta, D; Kaur, R | 1 |
Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL | 1 |
Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A | 1 |
Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K | 1 |
Böhme, A; Heinz, WJ; Silling, G | 1 |
Charles, JF; Daikh, DI; Eberle, C; Rooney, T | 1 |
Ciecko, SC; Scher, R | 1 |
Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S | 1 |
Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M | 1 |
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA | 1 |
Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM | 1 |
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
Huang, CY; Sun, PL; Tseng, HK | 1 |
Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N | 1 |
Katragkou, A; Roilides, E | 1 |
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A | 1 |
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A | 1 |
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R | 1 |
Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
Williams, D | 1 |
Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N | 1 |
Hockey, HP; Hope, WW; Troke, PF | 1 |
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL | 1 |
Dickmeyer, NJ; Kiel, PJ | 1 |
Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C | 1 |
Haagsma, CJ; Hendrix, R; Ruinemans, GM | 1 |
de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A | 1 |
Cui, Y; Jin, C; Li, X; Wu, N | 1 |
Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I | 1 |
Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C | 1 |
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL | 1 |
Lass-Flörl, C | 1 |
Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G | 1 |
de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P | 1 |
Chan, C; Chen, J; Colantonio, D; Seto, W | 1 |
Feng, AM; Wei, JY; Yu, WJ | 1 |
Hamada, Y; Kuroyama, M; Seto, Y; Yago, K | 1 |
Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L | 1 |
Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA | 1 |
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
Shen, YF; Sun, HL; Zhou, X | 1 |
Newton, EJ | 1 |
Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD | 1 |
Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR | 1 |
Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP | 1 |
Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA | 1 |
Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S | 1 |
Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S | 1 |
Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX | 1 |
Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO | 1 |
Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J | 1 |
Andes, D; Lepak, A | 1 |
Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A | 1 |
Abdi, RF; Al-Tawfiq, JA; Tarazi, AE | 1 |
Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M | 1 |
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W | 1 |
Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE | 1 |
Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
Atkinson, G; Lee, GA; McLintock, CA | 1 |
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K | 1 |
Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL | 1 |
Lu, HZ; Shen, YZ; Wang, ZY | 1 |
Berzins, IK; Naples, LM; Poll, CP | 1 |
Chen, J; Liang, L; Liu, D | 1 |
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
Arzeni, D; Astolfi, D; Catavitello, C; D'Antonio, D; Farina, C; Favaro, M; Fazii, P; Fontana, C; Hendrickx, M; Masciarelli, G; Pitzurra, L; Polilli, E; Savini, V; Sisti, M; Stubbe, D | 1 |
Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C | 1 |
Estes, LL; Wilson, JW; Zeuli, JD | 1 |
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T | 1 |
Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ | 1 |
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R | 1 |
Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL | 1 |
Yoshida, M | 1 |
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW | 1 |
Stevens, DA | 1 |
Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J | 1 |
Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP | 1 |
Greenberg, RN; Martin, CA; Roberts, S | 1 |
Garbino, J; Hirschel, B | 1 |
Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P | 1 |
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM | 1 |
Falk, R; Polacheck, I; Shapiro, M; Wolf, DG | 1 |
Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P | 1 |
Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD | 1 |
Chan, J | 1 |
Holzgrabe, U; Schäfer-Korting, M | 1 |
Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK | 1 |
Sutton, DA | 1 |
Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A | 1 |
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V | 1 |
Girmenia, C; Martino, P | 1 |
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Lutsar, I; Roffey, S; Troke, P | 1 |
Schäfer-Korting, M | 1 |
Gupta, AK; Tomas, E | 1 |
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV | 1 |
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD | 1 |
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C | 1 |
Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
Baden, LR; Cosimi, LA; Marty, FM | 1 |
Gothard, P; Rogers, TR | 1 |
Rubin, ZA; Somani, J | 1 |
Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D | 2 |
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M | 1 |
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR | 1 |
Aoun, M | 1 |
Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S | 1 |
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
Klastersky, J | 1 |
Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I | 1 |
Herbrecht, R | 1 |
Wingard, JR | 1 |
Comair, Y; Kanafani, ZA; Kanj, SS | 1 |
Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C | 1 |
Agrawal, AK; Sherman, LK | 1 |
Perfect, JR | 1 |
Marr, K | 1 |
Danaher, PJ | 1 |
Lowry, CM; Marty, FM | 1 |
Balwierz, W | 1 |
Chen, A; Sobel, JD | 1 |
Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A | 1 |
Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C | 1 |
Mohammedi, I; Padoin, C; Piens, MA; Robert, D | 1 |
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M | 1 |
Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
Böhme, A; Haas, A; Maschmeyer, G | 1 |
Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D | 1 |
Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I | 1 |
Steinbach, WJ | 1 |
Kofla, G; Ruhnke, M | 1 |
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD | 1 |
Keady, S; Thacker, M | 1 |
Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA | 1 |
Morace, G; Polonelli, L | 1 |
Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH | 1 |
Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V | 1 |
Chan-Tack, KM | 1 |
Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S | 1 |
Colombo, GL; Morlotti, L; Serra, G | 1 |
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
Chamilos, G; Kontoyiannis, DP | 1 |
Chamilos, G; Kontoyiannis, DP; Lewis, RE | 1 |
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
Ellis, D; Harkness, J; Kwong, T; Marriott, D | 1 |
Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV | 1 |
Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C | 1 |
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A | 1 |
Al-Attar, A; Redett, RJ; Williams, CG | 1 |
de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C | 1 |
Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N | 1 |
Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM | 1 |
Crum-Cianflone, N; Dull, M; Teneza-Mora, N | 1 |
Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA | 1 |
Jarque, I; Salavert, M | 1 |
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK | 1 |
Derendorf, H; Ihle, F; Theuretzbacher, U | 1 |
Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A | 1 |
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
Pemán, J; Zaragoza, R | 1 |
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
Björkholm, M; Cherif, H; Kalin, M | 1 |
Rokicka, M | 1 |
Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE | 1 |
Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T | 1 |
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
Beck, R; Kaben, U; Tintelnot, K | 1 |
Gopal, L; Sen, P; Sen, PR | 1 |
Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS | 1 |
Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A | 1 |
Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E | 1 |
Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME | 1 |
Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM | 1 |
Belousov, DIu; Veselov, AV | 1 |
Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ | 1 |
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
Scott, LJ; Simpson, D | 1 |
Maesaki, S | 2 |
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J | 1 |
Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J | 1 |
Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
Ho, DY; Lee, JD; Montoya, JG; Rosso, F | 1 |
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L | 1 |
Kontoyiannis, DP; Lewis, RE | 1 |
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K | 1 |
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA | 1 |
Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T | 1 |
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L | 1 |
Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ | 1 |
Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
Schlamm, HT; Supparatpinyo, K | 1 |
Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
Park, AJ; Tu, EY | 1 |
Kauffman, CA; Malani, AN | 1 |
Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M | 1 |
Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G | 1 |
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J | 1 |
Del Palacio, A; Pontón, J; Quindós, G | 1 |
Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G | 1 |
Alvarez Lerma, F | 1 |
Jarque, I; Sanz, MA | 1 |
Salavert, M; Solé, A | 1 |
Guarro, J; Pastor, FJ | 1 |
Chen, SC; Sorrell, TC | 1 |
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
Anten, S; Heddema, ER; Visser, O; Zweegman, AS | 1 |
Dunand, J; Paugam, A | 1 |
Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM | 1 |
Erwin, GE; Fitzgerald, JE | 1 |
Buadi, FK; McClune, B; Przepiorka, D | 1 |
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A | 1 |
Boot, B; Danho, C; Huynh, A; Mejdoubi, M | 1 |
Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V | 1 |
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ | 1 |
Ali, S; Whittle, AM | 1 |
Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT | 1 |
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL | 1 |
Andes, D; Smith, J | 1 |
Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O | 1 |
Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M | 1 |
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J | 1 |
Lipp, HP | 1 |
Guarro, J; Mariné, M; Ruíz-Cendoya, M | 1 |
Johnson, EM; Radford, SA; Warnock, DW | 1 |
Baquero, F | 1 |
Johnson, EM; Szekely, A; Warnock, DW | 1 |
Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
Chiou, CC; Groll, AH; Walsh, TJ | 1 |
Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB | 1 |
Niki, Y | 1 |
McDougal, EC; Nesky, MA; Peacock, JE | 1 |
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
Espinel-Ingroff, A | 1 |
Gigliotti, F; Wellington, M | 1 |
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
Marr, KA | 1 |
Dixon, CA; Goldberger, MJ; Powers, JH | 1 |
Hoffman, HL; Rathbun, RC | 1 |
Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S | 1 |
Dismukes, WE; Lee, J; Walsh, TJ | 1 |
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
Johnson, JR | 1 |
Cornely, OA; Heussel, CP; Ullmann, AJ | 1 |
Ghannoum, MA; Kuhn, DM | 1 |
121 review(s) available for voriconazole and Mycoses
Article | Year |
---|---|
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Combined Phialemonium curvatum and Acanthamoeba Keratitis: The Importance of Early Diagnosis and Specific Therapy.
Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Biguanides; Disinfectants; Drug Therapy, Combination; Early Diagnosis; Eye Infections, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Moxifloxacin; Mycoses; Ophthalmic Solutions; Slit Lamp Microscopy; Voriconazole | 2021 |
First Case of Subcutaneous Mycoses Caused by
Topics: Aged, 80 and over; Antifungal Agents; Basidiomycota; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; Ustilaginales; Voriconazole | 2021 |
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Lung infection caused by Blastoschizomyces capitatus without immunodeficiency: a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dyspnea; Humans; Lung; Male; Mycoses; Pneumonia; Voriconazole | 2022 |
Emergomyces pasteurianus in Man Returning to the United States from Liberia and Review of the Literature.
Topics: Aged; Humans; Liberia; Mycoses; Onygenales; United States; Voriconazole | 2023 |
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole | 2023 |
Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Middle Aged; Mortality; Mycoses; Observational Studies as Topic; Postoperative Care; Respiratory Tract Infections; Retrospective Studies; Scedosporium; Voriconazole | 2019 |
Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Febrile Neutropenia; Humans; Mycoses; Randomized Controlled Trials as Topic; Treatment Outcome; Voriconazole | 2020 |
Pseudozyma spp. human infections: A systematic review.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts | 2021 |
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole | 2020 |
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
Topics: Acremonium; Animals; Antifungal Agents; Arthritis; Blood; Central Nervous System Infections; Dermatomycoses; Drug Resistance, Fungal; Endocarditis; Eye Infections; Humans; Hypocreales; Invasive Fungal Infections; Mycetoma; Mycoses; Onychomycosis; Opportunistic Infections; Osteomyelitis; Peritonitis; Respiratory Tract Infections; Voriconazole | 2020 |
Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Mycoses; Voriconazole | 2021 |
Antifungal Prophylaxis After Lung Transplantation: Where Are We Now?
Topics: Adult; Antifungal Agents; Humans; Lung Transplantation; Mycoses; Transplant Recipients; Voriconazole | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Female; Humans; Lung Transplantation; Male; Mycetoma; Mycoses; Scedosporium; Switzerland; Transplant Recipients; Voriconazole; Young Adult | 2018 |
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole | 2018 |
Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
Topics: Adolescent; Antifungal Agents; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Voriconazole; Young Adult | 2018 |
Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Eye Infections, Fungal; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Mycoses; Postoperative Complications; Scedosporium; Scleritis; Tenon Capsule; Triamcinolone Acetonide; Voriconazole | 2018 |
Fungal Infection Caused by Geotrichum capitatum in a Severe Aplastic Anemia Patient: a Case Report and Review of the Literature.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Geotrichum; Humans; Mycoses; Severity of Illness Index; Voriconazole | 2018 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
[Central nervous system infection caused by Exophiala dermatitidis in a case and literature review].
Topics: Amphotericin B; Antifungal Agents; Brain; Central Nervous System Infections; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Exophiala; Fatal Outcome; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Mycoses; Radiography; Voriconazole | 2014 |
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole | 2014 |
[A case of filamentous fungal infection showing tumor-like expansion in the cisterns].
Topics: Aged; Antifungal Agents; Cisterna Magna; Diagnosis, Differential; Encephalitis; Female; Humans; Infusions, Spinal; Magnetic Resonance Imaging; Miconazole; Mycoses; Prednisolone; Pseudallescheria; Treatment Outcome; Voriconazole | 2014 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fluconazole; Fungemia; Humans; Middle Aged; Mycoses; Risk Factors; Voriconazole; Yeasts | 2014 |
Penicillium marneffei infection in a lung transplant recipient.
Topics: Adult; Antifungal Agents; Female; Humans; Lung Transplantation; Mycoses; Penicillium; Transplant Recipients; Travel; Treatment Outcome; Vietnam; Voriconazole | 2015 |
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.
Topics: Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review.
Topics: Antifungal Agents; Aspergillosis; Candidemia; Drug Monitoring; Humans; Mycoses; Voriconazole | 2015 |
Scedosporium apiospermum Otitis Complicated by a Temporomandibular Arthritis: A Case Report and Mini-Review.
Topics: Aged, 80 and over; Antifungal Agents; Arthritis; Head; Humans; Male; Mycoses; Otitis Externa; Scedosporium; Temporomandibular Joint; Temporomandibular Joint Disorders; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2015 |
Cladosporium keratitis - a case report and literature review.
Topics: Administration, Topical; Antifungal Agents; Cladosporium; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Middle Aged; Mycoses; Slit Lamp; Visual Acuity; Voriconazole | 2015 |
[Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment].
Topics: Anidulafungin; Antifungal Agents; Drug Combinations; Echinocandins; Fungi; Humans; Immunocompromised Host; Immunosuppression Therapy; Mycoses; Voriconazole | 2015 |
Voriconazole: How to Use This Antifungal Agent and What to Expect.
Topics: Antifungal Agents; Drug Interactions; Drug Monitoring; Humans; Mycoses; Voriconazole | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Biofilms; Defibrillators, Implantable; DNA, Intergenic; Endocarditis; Heart; Humans; Male; Mycoses; Sequence Analysis, DNA; Trichoderma; Voriconazole | 2016 |
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole | 2016 |
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Liver; Mycoses; Nervous System; Treatment Outcome; Voriconazole | 2016 |
Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Treatment Outcome; Voriconazole | 2016 |
Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis.
Topics: Antifungal Agents; Cytochrome P-450 CYP2C19; Genotype; Humans; Mycoses; Phenotype; Polymorphism, Genetic; Treatment Outcome; Voriconazole | 2016 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2009 |
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Pharmacology and clinical use of voriconazole.
Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Phototoxicity and photocarcinogenesis associated with voriconazole.
Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Therapeutic drug monitoring of voriconazole in children.
Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole | 2012 |
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole in clinical practice.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2002 |
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
[A silver lining on the horizon: new antimycotics].
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
New antifungal drugs and new clinical trials: interpreting results may be difficult.
Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
New antifungal agents.
Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2004 |
Voriconazole for serious fungal infections.
Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2004 |
[Voriconazole: a new weapon against invasive fungal infections].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Voriconazole: therapeutic review of a new azole antifungal.
Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Emerging azole antifungals.
Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole | 2006 |
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2006 |
Pharmacokinetic/pharmacodynamic profile of voriconazole.
Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2006 |
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Voriconazole safety: short review of clinical data].
Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole : a review of its use in the management of invasive fungal infections.
Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2007 |
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2008 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
[Role of voriconazole in critically ill patients with invasive mycoses].
Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole | 2007 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2000 |
Update on antifungal agents.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole | 2001 |
Review of the safety and efficacy of voriconazole.
Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole -- better chances for patients with invasive mycoses.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole | 2002 |
39 trial(s) available for voriconazole and Mycoses
Article | Year |
---|---|
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
Topics: Adult; Antifungal Agents; Chlorhexidine; Corneal Ulcer; Eye Infections, Fungal; Fungi; Humans; Keratitis; Mycoses; Natamycin; Nepal; Treatment Outcome; Voriconazole | 2022 |
The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Corneal Perforation; Corneal Stroma; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Injections, Intraocular; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Prognosis; Time Factors; Visual Acuity; Voriconazole; Young Adult | 2020 |
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
Topics: Administration, Oral; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Suppuration; Visual Acuity; Voriconazole | 2017 |
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing | 2013 |
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2013 |
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2014 |
[Clinical investigation of reduced-dose voriconazole on primary prevention in invasive fungal disease after allogeneic hematopoietic stem cell transplantation].
Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Postoperative Complications; Treatment Outcome; Voriconazole; Young Adult | 2014 |
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Vision, Ocular; Visual Acuity; Voriconazole | 2015 |
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2016 |
Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Drug Resistance, Multiple, Fungal; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Visual Acuity; Voriconazole | 2016 |
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
Topics: Adolescent; Adult; Aged; Antifungal Agents; China; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Survival Rate; Voriconazole; Young Adult | 2016 |
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole | 2012 |
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2011 |
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2012 |
Voriconazole for fungal corneal ulcers.
Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole | 2013 |
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
462 other study(ies) available for voriconazole and Mycoses
Article | Year |
---|---|
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
Topics: Antifungal Agents; Base Sequence; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Fusarium; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Species Specificity | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
New azoles with antifungal activity: Design, synthesis, and molecular docking.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Azoles; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship | 2011 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Topics: Amphotericin B; Antifungal Agents; Benzoates; Biofilms; Cinnamates; Drug Combinations; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Terpenes; Voriconazole | 2021 |
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Allergic fungal rhinosinusitis caused by Neoscytalidium dimidiatum: A case report: Allergic fungal rhinosinusitis due to Neoscytalidium dimidiatum.
Topics: Adult; Ascomycota; Female; Humans; Iran; Mycoses; Sinusitis; Voriconazole | 2022 |
Successful treatment of Talaromyces marneffei infection in a kidney transplant recipient with voriconazole followed by itraconazole for the first time.
Topics: Antifungal Agents; Humans; Itraconazole; Kidney Transplantation; Mycoses; Voriconazole | 2022 |
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of Gestation.
Topics: Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Pregnancy; Voriconazole | 2022 |
Severe Polyarthralgia After Kidney Transplant.
Topics: Agaricales; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Female; Hand; Humans; Kidney Transplantation; Middle Aged; Mycoses; Radiography; Voriconazole | 2022 |
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; India; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Randomized Controlled Trials as Topic; Voriconazole | 2022 |
Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Mice; Mycoses; Solubility; Voriconazole | 2022 |
The Effects of Intravitreal Administration of Antifungal Drugs on the Structure and Mechanical Properties Peripheral Blood Erythrocyte Surface in Rabbits.
Topics: Animals; Antifungal Agents; Erythrocytes; Micafungin; Mycoses; Rabbits; Voriconazole | 2022 |
PULMONARY AND COELOMIC MYCOSES DUE TO
Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole | 2022 |
Successful treatment of Talaromyces marneffei pneumonia in a HIV-negative renal transplantation recipient: A case report.
Topics: Antifungal Agents; HIV Infections; Humans; Kidney Transplantation; Moxifloxacin; Mycoses; Pneumonia; Tacrolimus; Talaromyces; Voriconazole | 2022 |
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report.
Topics: Adult; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; HIV; Humans; Male; Mycoses; Pericarditis, Tuberculous; Voriconazole | 2022 |
Manifestations, Prevalence, Management and Outcome of Invasive
Topics: Antifungal Agents; Aspergillosis; Cross-Sectional Studies; Humans; Liver Transplantation; Mycoses; Prevalence; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2024 |
Acremonium (Sarocladium) periprosthetic joint infection: case report, literature review, and proposed antifungal regimen.
Topics: Acremonium; Antifungal Agents; Female; Humans; Middle Aged; Mycoses; Prosthesis-Related Infections; Voriconazole | 2022 |
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole | 2023 |
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole.
Topics: Antifungal Agents; Female; Humans; Incidence; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mycoses; Prospective Studies; Retrospective Studies; Voriconazole | 2023 |
Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Everolimus; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2023 |
Palatal perforation caused by Alternaria alternata infection in an immunocompetent adolescent.
Topics: Adolescent; Alternaria; Biopsy; Humans; Male; Mycoses; Opportunistic Infections; Voriconazole | 2023 |
[First Hungarian report of Geotrichum capitatum/Saprochaete capitata infection in an immunocompromised child].
Topics: Antifungal Agents; Child; Female; Humans; Hungary; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Mycoses; Voriconazole | 2023 |
A successful management of fungal peritonitis caused by Rhodotorula glutinis in CAPD patient, coincident with onychomycosis by Penicillium sp: Case report.
Topics: Adult; Dialysis Solutions; Fluconazole; Humans; Male; Mycoses; Onychomycosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Voriconazole | 2023 |
Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Child, Preschool; China; Female; HIV-1; Humans; Infant; Itraconazole; Male; Mycoses; Retrospective Studies; Talaromyces; Voriconazole | 2019 |
Placental and breastmilk transfer of voriconazole to offspring from pregnant and lactating bottlenose dolphins (Tursiops truncatus).
Topics: Animals; Bottle-Nosed Dolphin; Female; Fetal Blood; Japan; Lactation; Maternal-Fetal Exchange; Milk; Mycoses; Placenta; Pregnancy; Respiratory Tract Infections; Voriconazole | 2020 |
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Risk Management; Voriconazole; Young Adult | 2020 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
First isolation of voriconazole-resistant Candida albicans, C. tropicalis, and Aspergillus niger from the blowholes of bottlenose dolphins (Tursiops truncatus).
Topics: Animals; Antifungal Agents; Aspergillus niger; Bottle-Nosed Dolphin; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Itraconazole; Japan; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2019 |
Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Repositioning; Drug Synergism; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Sertraline; Voriconazole | 2020 |
Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Fluorescence; Humans; Male; Mycoses; Reproducibility of Results; Voriconazole | 2020 |
Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.
Topics: Amphotericin B; Antifungal Agents; Blood Culture; Brazil; Diffusion; DNA, Intergenic; Humans; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Voriconazole | 2020 |
Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Mycoses; Prevalence; Prospective Studies; Spain; Voriconazole | 2020 |
Cladosporium Endogenous Endophthalmitis Mimicking Toxoplasma Retinochoroiditis.
Topics: Adult; Antifungal Agents; Aqueous Humor; Chorioretinitis; Cladosporium; DNA, Fungal; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Mycoses; Polymerase Chain Reaction; Toxoplasmosis, Ocular; Vitreous Body; Voriconazole | 2021 |
Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Mycoses; Risk Factors; Scedosporium; Voriconazole | 2020 |
Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
Topics: Antifungal Agents; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pharmacogenetics; Polymorphism, Single Nucleotide; Pregnane X Receptor; Procalcitonin; Retrospective Studies; Voriconazole | 2020 |
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole | 2019 |
Chronic fungal osteomyelitis of the tibia due to
Topics: Acremonium; Antifungal Agents; Chronic Disease; Humans; Immunocompetence; Male; Middle Aged; Mycoses; Osteomyelitis; Tibia; Treatment Outcome; Voriconazole | 2019 |
Brain abscess in patients with chronic kidney disease: A case-based approach to management in resource-limited settings.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Brain Abscess; Female; Humans; Kidney Transplantation; Linezolid; Male; Meropenem; Mycoses; Renal Insufficiency, Chronic; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2020 |
Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Topics: Administration, Intravenous; Age Factors; Aged; Antifungal Agents; China; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Patient Safety; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin, Human; Sex Factors; Voriconazole | 2020 |
Potential voriconazole associated posterior reversible leukoencephalopathy in children with malignancies: Report of two cases.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Magnetic Resonance Imaging; Male; Mycoses; Neoplasms; Posterior Leukoencephalopathy Syndrome; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole; Wilms Tumor | 2021 |
A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genotype; Humans; Male; Middle Aged; Mycoses; Phenotype; Polymorphism, Genetic; Prospective Studies; Voriconazole | 2020 |
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.
Topics: Anti-Infective Agents; Australia; Bacteria; Bacterial Infections; Clinical Decision-Making; Cross-Sectional Studies; Drug Monitoring; Fungi; Gentamicins; Health Personnel; Humans; Microbial Sensitivity Tests; Mycoses; Surveys and Questionnaires; Vancomycin; Voriconazole | 2020 |
Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Cornea; DNA, Fungal; Drug Resistance, Fungal; Female; Humans; Hypocreales; Itraconazole; Keratitis; Mexico; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycological Typing Techniques; Mycoses; Phylogeny; Voriconazole | 2021 |
Hypertrophic pachymeningitis caused by Schizophyllum sp.: a novel case report.
Topics: Aged; Female; Humans; Magnetic Resonance Imaging; Meningitis; Mycoses; Schizophyllum; Sinusitis; Voriconazole | 2021 |
Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports.
Topics: Antifungal Agents; Byssochlamys; Humans; Mycoses; Paecilomyces; Registries; Voriconazole | 2021 |
Influence of switching from intravenous to oral administration on serum voriconazole concentration.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Antifungal Agents; Drug Administration Routes; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Voriconazole | 2021 |
Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Humans; Induction Chemotherapy; Mycoses; Retrospective Studies; Talaromyces; Voriconazole | 2021 |
An Iris Tumor Secondary to
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Fluconazole; Humans; Iris Neoplasms; Male; Mycoses; Ophthalmic Solutions; Syphilis; Voriconazole | 2022 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole | 2021 |
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole | 2017 |
Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.
Topics: Antifungal Agents; Antineoplastic Agents; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mycoses; Myelodysplastic Syndromes; Retrospective Studies; Voriconazole | 2018 |
Assessment of high-priced systemic antifungal prescriptions.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Middle Aged; Multiple Organ Failure; Mycoses; Organ Transplantation; Retrospective Studies; Survival Rate; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Paecilomyces as a Cause of Lymph Nodes Enlargement in Hodgkin's Lymphoma.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child, Preschool; Diagnosis, Differential; Hodgkin Disease; Humans; Immunocompromised Host; Lymphadenopathy; Male; Mycoses; Paecilomyces; Positron Emission Tomography Computed Tomography; Voriconazole | 2017 |
Case of mycotic cyst caused by Scedosporium apiospermum developed liver dysfunction following administration of voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cysts; Female; Humans; Mycoses; Scedosporium; Voriconazole | 2017 |
Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Transplantation, Autologous; Transplantation, Homologous; Voriconazole | 2017 |
Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.
Topics: Antifungal Agents; Child; Female; Greece; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Treatment Outcome; Voriconazole | 2018 |
The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
Topics: Antifungal Agents; Blood Culture; Candida; Candidiasis; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Hospitalization; Hospitals, University; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pichia; Surveys and Questionnaires; Time Factors; Turkey; Voriconazole | 2017 |
PHARMACOKINETICS, EFFICACY, AND SAFETY OF VORICONAZOLE AND ITRACONAZOLE IN HEALTHY COTTONMOUTHS (AGKISTRODON PISCIVORUS) AND MASSASAUGA RATTLESNAKES (SISTRURUS CATENATUS) WITH SNAKE FUNGAL DISEASE.
Topics: Agkistrodon; Animals; Antifungal Agents; Ascomycota; Cloaca; Crotalus; Drug Delivery Systems; Itraconazole; Mycoses; Pilot Projects; Voriconazole | 2017 |
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
Topics: Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2018 |
[Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Humans; Invasive Fungal Infections; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2017 |
Reversible dysphagia secondary to guttural pouch mycosis in a gelding treated medically with voriconazole and surgically with carotid occlusion and esophagostomy.
Topics: Animal Structures; Animals; Antifungal Agents; Carotid Arteries; Deglutition Disorders; Esophagostomy; Horse Diseases; Horses; Male; Mycoses; Voriconazole | 2018 |
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Vision Disorders; Voriconazole | 2016 |
TREATMENT OF MYCOTIC RHINOSINUSITIS IN A BENNETT'S WALLABY ( MACROPUS RUFOGRISEUS) USING TOPICAL VORICONAZOLE SUSPENDED IN A REVERSE THERMODYNAMIC PLURONIC GEL.
Topics: Administration, Topical; Animals; Animals, Zoo; Antifungal Agents; Drug Compounding; Female; Gels; Macropodidae; Mycoses; Rhinitis; Sinusitis; Voriconazole | 2018 |
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole | 2018 |
Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Variation, Population; Comorbidity; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Voriconazole | 2018 |
Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child-Pugh Class C).
Topics: Administration, Oral; Antifungal Agents; Drug Monitoring; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Mycoses; Retrospective Studies; Severity of Illness Index; Voriconazole | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Skull; Talaromyces; Voriconazole | 2019 |
Fungal prostatic abscess erupting through the penis.
Topics: Adult; Antifungal Agents; Humans; Male; Mycoses; Penile Diseases; Pichia; Prostatic Diseases; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2018 |
[Primary Prophylatic Effect of Voriconazole Against Invasive Infection of Pulmonary Aspergillosis during Remission-Induction Chemotherapy for Acute Myeloid Leukemia].
Topics: Antifungal Agents; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2018 |
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Voriconazole; Young Adult | 2019 |
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Interactions; Drug Monitoring; Itraconazole; Ketoconazole; Male; Mycoses; Pyridines; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Voriconazole | 2019 |
A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer.
Topics: Adolescent; Antifungal Agents; Child; Female; Humans; Male; Mycoses; Neoplasms; Retrospective Studies; Voriconazole | 2019 |
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2019 |
Why do lung transplant patients discontinue triazole prophylaxis?
Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Application of laser capture microdissection and polymerase chain reaction in the diagnosis of Trichoderma longibrachiatum infection: a promising diagnostic tool for 'fungal contaminants' infection.
Topics: Antifungal Agents; Humans; Immunocompromised Host; Laser Capture Microdissection; Male; Middle Aged; Molecular Diagnostic Techniques; Mycoses; Polymerase Chain Reaction; Treatment Outcome; Trichoderma; Voriconazole | 2020 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
Topics: Administration, Oral; Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Immunocompromised Host; Incidence; Japan; Liver Function Tests; Male; Middle Aged; Mycoses; Oxygenases; Voriconazole | 2019 |
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole | 2013 |
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Preemptive treatment with voriconazole in lung transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Disseminated Ochroconis gallopava infection in a heart transplant patient.
Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole | 2013 |
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2013 |
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole | 2013 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2013 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms | 2014 |
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole | 2013 |
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2014 |
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Photo quiz: A patient with ulcerated nodules on his face.
Topics: Aged; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Face; Fatal Outcome; Humans; Male; Mycoses; Scedosporium; Skin Neoplasms; Voriconazole | 2014 |
Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.
Topics: Antifungal Agents; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Lipopeptides; Mycoses; Treatment Failure; Treatment Outcome; Turkey; Voriconazole | 2014 |
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cord Blood Stem Cell Transplantation; Drug Interactions; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Premedication; Prospective Studies; Risk Factors; Transplantation Conditioning; Vidarabine; Voriconazole; Young Adult | 2014 |
Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics.
Topics: Aged; Antifungal Agents; Cimetidine; Cytochrome P-450 CYP2C19; Debridement; Drug Interactions; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pharmacogenetics; Scedosporium; Voriconazole | 2014 |
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Alopecia and nail changes associated with voriconazole therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole | 2014 |
Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report.
Topics: Adult; Aneurysm; Antifungal Agents; Female; Humans; Meningitis, Fungal; Mycoses; Voriconazole | 2014 |
A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Developing Countries; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycobacterium tuberculosis; Mycoses; Postoperative Complications; Scedosporium; Transplant Recipients; Transplantation, Homologous; Tuberculosis; Voriconazole | 2014 |
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report.
Topics: Antifungal Agents; Antineoplastic Agents; Fungemia; Humans; Male; Middle Aged; Mycoses; Stem Cell Transplantation; Trichoderma; Voriconazole | 2014 |
Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Prospective Studies; Tacrolimus; Voriconazole | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Experimental treatment of Curvularia infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.
Topics: Adult; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Retrospective Studies; Scedosporium; Voriconazole | 2014 |
Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Mycoses; Paecilomyces; Retrospective Studies; Scleritis; Voriconazole; Young Adult | 2014 |
[Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
Topics: Antifungal Agents; Candidiasis; Caspofungin; Child; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Mycoses; Neoplasms; Pediatrics; Practice Guidelines as Topic; Voriconazole | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult | 2015 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
Topics: Administration, Oral; Aged; Antifungal Agents; Drug Interactions; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycoses; Pneumonia; Sirolimus; Voriconazole | 2015 |
Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Voriconazole phototoxicity in children: a retrospective review.
Topics: Adolescent; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Causality; Child; Comorbidity; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Male; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Voriconazole; White People | 2015 |
Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient.
Topics: Adolescent; Antifungal Agents; Humans; Liver Transplantation; Male; Mycoses; Paecilomyces; Peritonitis; Postoperative Complications; Voriconazole | 2015 |
Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.
Topics: Aged; Antifungal Agents; Cohort Studies; Cytochrome P-450 CYP2C19; Female; Genotyping Techniques; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pharmacogenetics; Pilot Projects; Treatment Outcome; Voriconazole | 2015 |
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.
Topics: Antifungal Agents; Chemoprevention; Clinical Trials as Topic; Cost-Benefit Analysis; Diagnostic Tests, Routine; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Micafungin; Mycoses; Neutropenia; Retrospective Studies; Voriconazole | 2015 |
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Scedosporium; Voriconazole | 2015 |
Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.
Topics: Aged; Antifungal Agents; beta-Glucans; Endocarditis; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Multiple Organ Failure; Mycoses; Naphthalenes; Proteoglycans; Scedosporium; Terbinafine; Voriconazole | 2015 |
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.
Topics: Aged, 80 and over; Anterior Chamber; Antifungal Agents; Corneal Stroma; Eye Infections, Fungal; Female; Humans; Injections; Keratitis; Male; Middle Aged; Mycoses; Voriconazole | 2015 |
Impact of risk stratification on the duration of caspofungin therapy for invasive fungal disease in acute leukemic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Middle Aged; Mycoses; Retrospective Studies; Risk; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Prescriptions; Drug Utilization; Echinocandins; England; Female; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2015 |
Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Interactions; Floxacillin; Humans; Mycoses; Scedosporium; Voriconazole | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating | 2015 |
Antifungal Treatment in Stem Cell Transplantation Centers in Turkey.
Topics: Adult; Allografts; Amphotericin B; Antifungal Agents; Child; Cross Infection; Diagnostic Tests, Routine; Drug Substitution; Drug Therapy, Combination; Drug Utilization; Febrile Neutropenia; Health Care Surveys; Health Facilities; Humans; Infection Control; Mycoses; Stem Cell Transplantation; Transplantation, Autologous; Turkey; Voriconazole | 2016 |
Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Thailand; Voriconazole; Young Adult | 2015 |
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole | 2015 |
First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cystic Fibrosis; Echinocandins; Eurotiales; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pharynx; Sequence Analysis, DNA; Slovenia; Voriconazole; Young Adult | 2015 |
Arthrographis kalrae arthritis: a new case report.
Topics: Aged; Antifungal Agents; Arthritis; Arthroscopy; Ascomycota; Humans; Knee; Male; Mycoses; Treatment Outcome; Voriconazole | 2015 |
Cutaneous and systemic mycoses from infection with Lecanicillium spp. in captive Guthega skinks (Liopholis guthega).
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Autopsy; Benzalkonium Compounds; Biguanides; Endangered Species; Female; Lizards; Male; Mycoses; Sequence Analysis, DNA; Victoria; Voriconazole | 2015 |
Liposomal voriconazole (VOR) formulation for improved ocular delivery.
Topics: Animals; Antifungal Agents; Cattle; Cholesterol; Fatty Acids, Monounsaturated; Keratitis; Liposomes; Microscopy, Electron, Transmission; Mycoses; Phosphatidylcholines; Quaternary Ammonium Compounds; Swine; Voriconazole | 2015 |
Successful treatment of Batrachochytrium salamandrivorans infections in salamanders requires synergy between voriconazole, polymyxin E and temperature.
Topics: Animals; Antifungal Agents; Chytridiomycota; Colistin; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Mycoses; Temperature; Urodela; Voriconazole | 2015 |
Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.
Topics: Chemoprevention; Costs and Cost Analysis; Cytochrome P-450 CYP2C19; Genotyping Techniques; Humans; Leukemia, Myeloid, Acute; Models, Statistical; Mycoses; Voriconazole | 2015 |
Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations.
Topics: Aged; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Mycoses; Periostitis; Radiography, Thoracic; Tomography, X-Ray; Voriconazole | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.
Topics: Academic Medical Centers; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Mycoses; Prospective Studies; Voriconazole; Young Adult | 2015 |
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Voriconazole; Yeasts | 2015 |
Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia.
Topics: Adult; Aged; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Female; Host-Pathogen Interactions; Humans; Immune Tolerance; Immunocompromised Host; Male; Middle Aged; Mycoses; Paecilomyces; Queensland; Retrospective Studies; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult | 2015 |
Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole.
Topics: Adult; Allografts; Female; Fluorides; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Musculoskeletal Pain; Mycoses; Retrospective Studies; Voriconazole | 2016 |
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections.
Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Organ Transplantation; Time Factors; Voriconazole | 2015 |
The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.
Topics: Adolescent; Antifungal Agents; Ascomycota; Coinfection; Echinocandins; Emericella; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Mycoses; Sputum; Voriconazole | 2016 |
Scedosporium apiospermum causing brain abscess in a renal allograft recipient.
Topics: Adult; Antifungal Agents; Brain Abscess; Combined Modality Therapy; Drainage; Fatal Outcome; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Mycoses; Postoperative Period; Scedosporium; Transplant Recipients; Voriconazole | 2015 |
Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole.
Topics: Administration, Ophthalmic; Antifungal Agents; Beauveria; Corneal Ulcer; Female; Humans; Middle Aged; Mycoses; Ophthalmic Solutions; Voriconazole | 2016 |
Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Algorithms; Allografts; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Polymorphism, Genetic; Precision Medicine; Voriconazole | 2016 |
Voriconazole Concentrations in Cerebrospinal Fluid During Prophylactic Use in Children with Acute Myelogenous Leukemia.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Mycoses; Voriconazole; Young Adult | 2016 |
Isavuconazole: a role for the newest broad-spectrum triazole.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2016 |
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Retrospective Studies; Voriconazole; White People; Young Adult | 2016 |
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole | 2016 |
In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Base Sequence; Caspofungin; DNA, Fungal; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhizopus; Tubulin; Voriconazole | 2016 |
Fungal Keratitis Caused by Exserohilum, An Emerging Pathogen.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; Communicable Diseases, Emerging; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity; Voriconazole; Young Adult | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Pulmonary Infection Secondary to Chrysosporium zonatum in an Immunocompetent Man.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Chrysosporium; Humans; Lung; Male; Middle Aged; Mycoses; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2016 |
Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Eye Diseases; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Opportunistic Infections; Peptide Hydrolases; Phospholipases; Virulence; Virulence Factors; Voriconazole | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Body Weight; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Injections, Intravenous; Lansoprazole; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Rabeprazole; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Voriconazole; Young Adult | 2016 |
Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.
Topics: Adult; Aged; Antifungal Agents; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Hospitals, Special; Humans; India; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Ophthalmology; Prognosis; Retrospective Studies; Scedosporium; Tertiary Care Centers; Visual Acuity; Voriconazole; Young Adult | 2016 |
Scedosporium apiospermum: a rare cause of malignant otitis externa.
Topics: Aged; Antifungal Agents; Ear, External; Humans; Male; Mycoses; Otitis Externa; Scedosporium; Voriconazole | 2016 |
A Rare Central Nervous System Fungal Infection Resulting from Brown Heroin Use.
Topics: Antifungal Agents; Candida; Central Nervous System Diseases; Cerebral Ventriculitis; Diagnosis, Differential; Emergency Service, Hospital; Endophthalmitis; Heroin; Humans; Male; Meningitis; Mycoses; Substance Abuse, Intravenous; Visual Fields; Voriconazole; Young Adult | 2017 |
Scedosporium prolificans Otitis Externa.
Topics: Adolescent; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Mycoses; Naphthalenes; Otitis Externa; Rosaniline Dyes; Scedosporium; Terbinafine; Treatment Outcome; Voriconazole | 2016 |
Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.
Topics: Animals; Antifungal Agents; Brain; Humans; Mice; Microbial Sensitivity Tests; Mycoses; Predictive Value of Tests; Scedosporium; Voriconazole | 2017 |
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fatal Outcome; Female; Fungemia; Humans; Leukemia; Lipopeptides; Moths; Mycoses; Opportunistic Infections; Saccharomycetales; Voriconazole; Young Adult | 2016 |
Successful treatment of Talaromyces amestolkiae pulmonary infection with voriconazole in an acute lymphoblastic leukemia patient.
Topics: Adult; Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Talaromyces; Voriconazole; Young Adult | 2017 |
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Topics: Antifungal Agents; Bacterial Adhesion; beta-Glucans; Biofilms; Catechin; Colistin; Cystic Fibrosis; Echinocandins; Exophiala; Farnesol; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2017 |
PharmGKB summary: voriconazole pathway, pharmacokinetics.
Topics: Antifungal Agents; Aspergillus; Candida; Fusarium; Humans; Mycoses; Pharmacogenetics; Scedosporium; Voriconazole | 2017 |
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
[Use of topical voriconazole in Alternaria keratitis].
Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole | 2009 |
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2009 |
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Scedosporium apiospermum skeletal infection in an immunocompetent child.
Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole | 2009 |
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole | 2009 |
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole | 2010 |
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole | 2009 |
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Practice patterns in the management of fungal corneal ulcers.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Keratitis resulting from Thielavia subthermophila Mouchacca.
Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole | 2009 |
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
Voriconazole concentrations and outcome of invasive fungal infections.
Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole | 2011 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
How many steps along the path is too far?
Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole pharmacokinetics and pharmacodynamics in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult | 2010 |
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole | 2009 |
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2010 |
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2010 |
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole | 2010 |
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2010 |
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2010 |
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole | 2010 |
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole | 2010 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2011 |
Fusarium sepsis, voriconazole, and the skin.
Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole | 2010 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2010 |
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole | 2010 |
[Rhodotorula glutinis sepsis. A case report].
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole | 2010 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fungal spinal cord compression in metastatic synovial sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole | 2011 |
Fusarium keratitis 3 weeks after healed corneal cross-linking.
Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult | 2010 |
Oral voriconazole dose in children: one size does not fit all.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2010 |
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2011 |
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult | 2011 |
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2011 |
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2011 |
A case of bovine valve endocarditis caused by Engyodontium album.
Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole | 2011 |
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole | 2011 |
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult | 2010 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2011 |
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2011 |
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2011 |
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
The effect of enteral nutrition supplements on serum voriconazole levels.
Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole | 2012 |
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole | 2011 |
Dosing voriconazole in an obese patient.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole | 2011 |
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult | 2011 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult | 2012 |
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Administration of voriconazole in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole | 2012 |
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Scedosporium apiospermum keratomycosis in a dog.
Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole | 2012 |
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2012 |
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-induced phototoxicity in children.
Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole | 2012 |
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Management of recurrent Paecilomyces lilacinus keratitis.
Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2013 |
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2012 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales | 2012 |
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole | 2013 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.
Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal; Fluconazole; Humans; Italy; Leukemia; Male; Metschnikowia; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Phylogeny; Pigments, Biological; Pyrazines; Sequence Analysis, DNA; Sputum; Voriconazole | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole | 2013 |
Evaluation of intravenous voriconazole in patients with compromised renal function.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole | 2013 |
Reflections on the approach to treatment of a mycologic disaster.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole | 2013 |
Schizophyllum commune: a new organism in eye infection.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Successful treatment of disseminated fusariosis.
Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Comment: caspofungin acetate for treatment of invasive fungal infections.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Improving the mouse model for studying the efficacy of voriconazole.
Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole | 2003 |
Voriconazole in the treatment of invasive mold infections in transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole | 2003 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole | 2004 |
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Effect of voriconazole on a corneal abscess caused by fusarium.
Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole-induced musical hallucinations.
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2005 |
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated fusarium infection in two neutropenic children].
Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole in the treatment of invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2005 |
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole | 2005 |
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2005 |
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Endogenous Phialemonium curvatum endophthalmitis.
Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Black fluid from a traumatic wound.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection | 2006 |
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2006 |
Fusarium oxysporum pneumonia in an immunocompetent host.
Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2006 |
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole | 2006 |
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
[Keratomycosis due to Cylindrocarpon lichenicola].
Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Voriconazole prophylaxis in lung transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2006 |
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole | 2006 |
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole | 2006 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
Voriconazole and fungal keratitis: a report of two treatment failures.
Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2006 |
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Management of tunnel fungal infection with voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole | 2007 |
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
The fusarium keratitis outbreak: not done yet?
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2007 |
Third-time lung transplant using extended criteria lungs.
Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole | 2007 |
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2007 |
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole | 2009 |
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Recurrent Trichosporon asahii glossitis: a case report.
Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole | 2008 |
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole | 2008 |
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2008 |
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole | 2008 |
Combined therapy in treatment of murine infection by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2008 |
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1997 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Voriconazole. UK 109496.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |
Empirical antifungal therapy--new options, new tradeoffs.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
Decisions about voriconazole versus liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |